A collaborative design NGS panel for hematologic malignancy and oncology analysis. Provides actionable mutation detection for informed treatment decisions in hematologic cancers. Available as a pre-designed panel ready to order.
Manufactured by
United Kingdom
Nonacus is a UK-based leader in precision oncology, transforming how cancer is detected and managed. Headquartered in Birmingham and working with scientists and clinicians worldwide, we are building an end-to-end genetic testing workflow designed to make early cancer detection simpler, faster, and more accessible.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Genes 2Me Private Ltd
India · 6 relevant products
GENETRON HEALTH (BEIJING) CO., LTD
China · 3 relevant products
Burning Rock Dx Co. Ltd.
China · 3 relevant products
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 3 relevant products
YouSeq
United Kingdom · 2 relevant products
BioChain (Beijing) Science & Technology. Inc.
China · 1 relevant product
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 1 relevant product
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept
India · 3 relevant products
Biopsense Oy
Finland · 1 relevant product
Rayto Life and Analytical Sciences Co., Ltd.
China · 1 relevant product
44 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 94 closest product alternatives
Genes 2Me Private Ltd · India
Genomic sequencing panel for cancer-related mutation and biomarker detection. Supports precision oncology treatment planning and selection.
GENETRON HEALTH (BEIJING) CO., LTD · China
A comprehensive genomic profiling test for tumor patients providing information on 831 cancer-related genes in a single test. The integrated analysis results support precision targeted therapy selection for cancer patients.
Burning Rock Dx Co. Ltd. · China
Next-generation sequencing panel for comprehensive cancer genomic profiling. Identifies mutations, copy number variations, and other genetic alterations to guide personalized treatment strategies.
Genes 2Me Private Ltd · India
Precision NGS panel containing 774 genes designed for oncology and clinical genomics applications. Enables comprehensive genetic profiling for accurate detection of clinically relevant variants in cancer diagnostics.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Comprehensive diagnostic panel for personalized treatment selection in cardiovascular and oncology diseases. Analyzes multiple genetic and molecular markers to guide clinical decision-making.
YouSeq · United Kingdom
An NGS-based panel for detection of inherited genetic mutations associated with hereditary cancer syndromes. Enables identification of cancer predisposition for risk stratification and preventive clinical decision-making.
BioChain (Beijing) Science & Technology. Inc. · China
Next-generation sequencing-based multiplex cancer screening panel for simultaneous detection of multiple cancer types. This advanced molecular diagnostic test enables comprehensive cancer risk stratification from single blood samples. The product is in development as part of the company's precision oncology pipeline.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Precision medicine diagnostic test for cancer screening and early detection. Part of the comprehensive oncology testing portfolio covering multiple cancer types.
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept · India
Targeted diagnostic panel for detecting mutations and fusion genes in acute lymphoblastic leukemia. Supports prognostic stratification and identification of therapeutic targets.
Biopsense Oy · Finland
Blood test panel for detecting and characterizing genetic and epigenetic mutations in circulating tumor DNA. Helps determine cancer origin, measure tumor burden, and identify new mutations during targeted therapy treatment.
Rayto Life and Analytical Sciences Co., Ltd. · China
Multi-analyte immunoassay for cancer screening and monitoring biomarkers. Supports oncology patient management and follow-up.
TRUPCR Europe Ltd · United Kingdom
A diagnostic panel kit for myeloproliferative neoplasm testing. Designed to detect multiple MPN-associated mutations and markers in a single comprehensive test.
82 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products